Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Andreas Mock

Showing results (11-20 of 67) with videos related to

Pageof 7
Sort By:
Frontiers in Oncology|June 28, 2021
EGFR and PI3K Pathway Activities Might Guide Drug Repurposing in HPV-Negative Head and Neck CancersAndreas Mock, Michaela Plath, Julius Moratin, et al.
Breast Care (Basel, Switzerland)|February 22, 2024
Reimbursement in the Context of Precision Oncology Approaches in Metastatic Breast Cancer: Challenges and ExperiencesConstantin Pixberg, Markus Schulze, Lars Buschhorn, et al.
Journal of Neuro-Oncology|June 27, 2016
Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysisChristine Jungk, Moritz Scherer, Andreas Mock, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|February 19, 2026
Antinuclear antibody (ANA) level and blood-profile in Oral lichen planus patients: A cross-sectional studyKatharina Theresa Obermeier, Wenko Smolka, Paris Liokatis, et al.
Cancer Immunology, Immunotherapy : CII|November 9, 2019
Serum very long-chain fatty acid-containing lipids predict response to immune checkpoint inhibitors in urological cancersAndreas Mock, Stefanie Zschäbitz, Romy Kirsten, et al.
Anticancer Research|April 13, 2016
Combined Treatment of ATRA with Epigenetic Drugs Increases Aggressiveness of Glioma XenograftsThomas Schmoch, Zoltan Gal, Andreas Mock, et al.
Pathologie (Heidelberg, Germany)|February 5, 2024
[Explainable artificial intelligence in pathology]Frederick Klauschen, Jonas Dippel, Philipp Keyl, et al.
Annual Review of Pathology|October 23, 2023
Toward Explainable Artificial Intelligence for Precision PathologyFrederick Klauschen, Jonas Dippel, Philipp Keyl, et al.
Oncotarget|May 20, 2021
Perioperative changes in the plasma metabolome of patients receiving general anesthesia for pancreatic cancer surgeryJohanna Mock-Ohnesorge, Andreas Mock, Thilo Hackert, et al.
Cancers|December 10, 2021
Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In VivoTao Yu, Junguo Cao, Montadar Alaa Eddine, et al.
Pageof 7

Showing results (11-20 of 67) with videos related to

Sort By:
Pageof 7
Frontiers in Oncology|June 28, 2021
EGFR and PI3K Pathway Activities Might Guide Drug Repurposing in HPV-Negative Head and Neck CancersAndreas Mock, Michaela Plath, Julius Moratin, et al.
Breast Care (Basel, Switzerland)|February 22, 2024
Reimbursement in the Context of Precision Oncology Approaches in Metastatic Breast Cancer: Challenges and ExperiencesConstantin Pixberg, Markus Schulze, Lars Buschhorn, et al.
Journal of Neuro-Oncology|June 27, 2016
Prognostic value of the extent of resection in supratentorial WHO grade II astrocytomas stratified for IDH1 mutation status: a single-center volumetric analysisChristine Jungk, Moritz Scherer, Andreas Mock, et al.
Journal of Cranio-Maxillo-Facial Surgery : Official Publication of the European Association for Cranio-Maxillo-Facial Surgery|February 19, 2026
Antinuclear antibody (ANA) level and blood-profile in Oral lichen planus patients: A cross-sectional studyKatharina Theresa Obermeier, Wenko Smolka, Paris Liokatis, et al.
Cancer Immunology, Immunotherapy : CII|November 9, 2019
Serum very long-chain fatty acid-containing lipids predict response to immune checkpoint inhibitors in urological cancersAndreas Mock, Stefanie Zschäbitz, Romy Kirsten, et al.
Anticancer Research|April 13, 2016
Combined Treatment of ATRA with Epigenetic Drugs Increases Aggressiveness of Glioma XenograftsThomas Schmoch, Zoltan Gal, Andreas Mock, et al.
Pathologie (Heidelberg, Germany)|February 5, 2024
[Explainable artificial intelligence in pathology]Frederick Klauschen, Jonas Dippel, Philipp Keyl, et al.
Annual Review of Pathology|October 23, 2023
Toward Explainable Artificial Intelligence for Precision PathologyFrederick Klauschen, Jonas Dippel, Philipp Keyl, et al.
Oncotarget|May 20, 2021
Perioperative changes in the plasma metabolome of patients receiving general anesthesia for pancreatic cancer surgeryJohanna Mock-Ohnesorge, Andreas Mock, Thilo Hackert, et al.
Cancers|December 10, 2021
Receptor-Tyrosine Kinase Inhibitor Ponatinib Inhibits Meningioma Growth In Vitro and In VivoTao Yu, Junguo Cao, Montadar Alaa Eddine, et al.
Pageof 7